Garmin powers live data for Oakley Meta Vanguard AI glasses
Meta AI app from the Garmin Connect IQ Store sends athletes real-time training insights and visual status LED updates OLATHE, Kan., Sept. 17, 2025 /PRNewswire/... Read more.
Results of China Phase III Clinical Study of Telitacicept for Generalized Myasthenia Gravis Selected for Oral Presentation at 2025 AANEM Annual Meeting
YANTAI, China, Sept. 17, 2025 /PRNewswire/ — RemeGen (688331.SH/09995.HK) announced that the 48-week open-label extension (OLE) data from China Phase III clinical... Read more.
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
SHANGHAI, Sept. 17, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell... Read more.
NAVER CEO Choi Soo-yeon Appointed to UN Global Compact Board of Directors, Strengthening International Partnerships for “AI Governance”
– CEO Choi recognized for her leadership in global dialogues and cooperation to advance safe AI development and establish a digital ecosystem – Sanda... Read more.
Marketing Maven Ranked Top 10 PR Firm in Los Angeles by O’Dwyer’s in 2025 Rankings Report
Integrated Marketing and PR Firm, Marketing Maven, Receives Top 10 Recognition For 2024 Agency Billings Encompassing The Verticals of Healthcare, Finance, Professional... Read more.
Nuix Wins Multiyear Contract with German Tax Authority to Strengthen Investigative and Regulatory Capabilities
SYDNEY, Sept. 17, 2025 /PRNewswire/ — Nuix (‘the Company’, ASX: NXL) today announces it has won a multiyear contract to supply forensic analysis... Read more.
Netskope Announces Pricing of Initial Public Offering
SANTA CLARA, Calif., Sept. 17, 2025 /PRNewswire/ — Netskope, a leader in modern security and networking for the cloud and AI era, today announced the pricing... Read more.
Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025
–Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne compared... Read more.
Nabors Energy Transition Corp. II Announces Extension of Deadline to Complete Business Combination
HOUSTON, Sept. 17, 2025 /PRNewswire/ — Nabors Energy Transition Corp. II (Nasdaq: NETD) (“NETD” or the “Company”) announced that its... Read more.
MIDAS and OLEON join forces to advance sustainable immersion cooling for data centers
AUSTIN, Texas, Sept. 17, 2025 /PRNewswire/ — MIDAS, a pioneer in immersion cooling for data centers, is partnering with Oleon, a trusted provider of sustainable,... Read more.